Zobrazeno 31 - 40
of 338
pro vyhledávání: '"Hans A. Messner"'
Autor:
Dennis Dong Hwan Kim, Hans A. Messner, Auro Viswabandya, Nada Hamad, Joon Ho Moon, Elizabeth Shin, Marc Poch Martell, Jeffrey H. Lipton, Sang Kyun Sohn, Fotios V. Michelis, Jieun Uhm
Publikováno v:
European journal of haematology. 99(2)
An increase in large granular lymphocytes (LGL) is frequently seen in patients following allogeneic hematopoietic cell transplantation (allo-HCT) and it has been associated with better outcomes in some reports. We assessed 826 consecutive patients at
Autor:
John Kuruvilla, Dennis Dong Hwan Kim, Jeffrey H. Lipton, David Loach, Matthew Seftel, Jieun Uhm, Hans A. Messner, Fotios V. Michelis, Vikas Gupta
Publikováno v:
European Journal of Haematology. 93:273-280
Allogeneic hematopoietic cell transplantation (HCT) is potentially curative for acute myeloid leukemia (AML). Impact of lymphocyte recovery on post-transplant outcomes has been suggested but reports are conflicting. We evaluated the impact of lymphoc
Autor:
Jeffrey H. Lipton, John Kuruvilla, Vikas Gupta, Dennis Dong Hwan Kim, Eshetu G. Atenafu, Suzanne Kamel-Reid, Laura Ellis, Jieun Uhm, Anna Lambie, Hans A. Messner, Mohamed Shanavas
Publikováno v:
Leukemia & Lymphoma. 55:2398-2401
Autor:
Jieun Uhm, Vikas Gupta, D.H. Kim, H-H Won, Jeffrey H. Lipton, L. Cheng, Nada Hamad, Wei Xu, S Su, John Kuruvilla, Hans A. Messner
Publikováno v:
Bone Marrow Transplantation. 49:649-656
We aimed to develop a risk model, based on single-nucleotide polymorphism (SNP) markers associated with an increased risk of organ-specific GVHD in 394 transplant pairs. A total of 259 SNPs were genotyped in 53 genes and evaluated for their associate
Autor:
John Kuruvilla, Jieun Uhm, Joon Ho Moon, Sang Kyun Sohn, Vikas Gupta, Jeffrey H. Lipton, Matthew D. Seftel, Nada Hamad, Naheed Alam, Hans A. Messner, Dennis Dong Hwan Kim
Publikováno v:
Annals of hematology. 96(5)
The CIBMTR chronic graft-versus-host disease (cGVHD) risk score can be refined and improved for better prognostic stratification. Three hundred and seven consecutive patients diagnosed with cGVHD by the NIH consensus criteria were retrospectively rev
Autor:
Hans A. Messner, Auro Viswabandya, Fotios V. Michelis, Maria Rhida Bautista, Dennis Dong Hwan Kim, Wilson Lam, Santhosh Thyagu, Rajat Kumar, Arjun Law, Jeffrey H. Lipton
Publikováno v:
Blood. 132:3403-3403
BACKGROUND: Systemic immunosuppression (SIS) is the standard treatment for significant acute and chronic graft versus host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). Previous studies have shown that 30-70% of patients r
Autor:
Santhosh Thyagu, Jeffrey H. Lipton, Wilson Lam, Auro Viswabandya, Warren Fingrut, Arjun Law, Hans A. Messner, Dennis Dong Hwan Kim, Fotios V. Michelis, Rajat Kumar
Publikováno v:
Blood. 132:3454-3454
Background: Allogeneic hematopoietic stem cell transplantation (HCT) is a curative therapy for many hematologic and non-hematologic diseases; however, it is associated with significant morbidity and mortality. Many studies have shown that elevated pr
Autor:
Dennis Dong Hwan Kim, Wilson Lam, Auro Viswabandya, Jeffrey H. Lipton, Santhosh Thyagu, Eshetu G. Atenafu, Arjun Law, Fotios V. Michelis, Mohammed A. Marei, Hans A. Messner, Rajat Kumar
Publikováno v:
Blood. 132:4670-4670
Introduction: Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for the treatment of various hematological diseases, in part due to the effect of conditioning chemotherapy, and in part due to graft-versus-malignancy eff
Autor:
Kenneth J. Craddock, Vikas Gupta, Hans A. Messner, James A. Kennedy, Joseph M. Brandwein, Aaron D. Schimmer, Eshetu G. Atenafu, Mark D. Minden, Jeffrey H. Lipton, Karen W.L. Yee, Andre C. Schuh
Publikováno v:
Blood. 121:2725-2733
Leukemic transformation (LT) is a rare but fatal complication of Philadelphia-negative myeloproliferative neoplasms (MPNs) for which optimal treatment strategies are not known. At our center, we have adopted a treatment approach for LT where patients
Autor:
Ghuzayel Aldawsari, Tony Panzarella, Vikas Gupta, Hong Chang, Hans A. Messner, Jeffrey H. Lipton, John Kuruvilla, Dennis Dong Hwan Kim
Publikováno v:
Bone Marrow Transplantation. 48:1104-1111
A total of 418 patients receiving hematopoietic SCT and surviving beyond day 100 were examined for the occurrence of large granular lymphocytes (LGLs). LGL lymphocytosis was defined as the presence of at least two of the following criteria: (1) susta